Truist Securities’ Post

Our CEO Njaal Kind will give a company presentation followed by a discussion and Q&A session on Investorweb tomorrow 2nd May. Tune in to learn more about Gentian Diagnostics and what we do #DiagnosticEfficiency

And they’re off...! For the week that’s in it, we thought it might be interesting and relevant to perception of luck and skill. Our investment partners in Dimensional Advisors have published a fascinating article on this concept as it relates to investing. https://lnkd.in/eYijcWES #investmentadvice #financialplanning ##moneyvalues #dfa #behaviouralfinance #balance #fundmanagement #pharma #medtech #tech

Amidst all the effort at #jpm2024 to finance innovation, we should also be talking about how to protect it from the wrong stroke of the pen. Prepare with by reading the latest Semper Maior: Spirits Rising report from the team at RA Capital Management https://lnkd.in/e-r_F2zg (note: your email will give you access to the report. We're gathering emails so we don't have to rely on social media like this to reach folks in biotech). RApport | Biotech Insight & Opinion

This Janmashtami, we're excited to bring you a special video featuring Mr. Sumeet Bagadia, our esteemed Executive Director and stock market expert. In this video, Mr. Sumeet Bagadia shares his insights on the top stock pick for investors, offering a unique perspective on the market and how it can benefit investors specifically. He'll take you through the stock, providing valuable insights and it's investment opportunities. Whether you're a seasoned investor or new to the market, this video is packed with valuable tips and strategies that will help you make informed decisions and take control of your financial future. From understanding market trends to selecting the stocks, Mr. Sumeet Bagadia has got you covered. So, join us in celebrating Janmashtami by tuning in to this must-watch video. Mr. Sumeet Bagadia's top stock pick are sure to inspire and empower you to take charge of your financial success. Don't miss out! 👉 Choice Equity Broking Private Limited - Research Analyst (SEBI Reg. No. INH000000222) 👉For disclaimer and disclosure please refer the link - https://lnkd.in/dDhZC7xV 👉 Disclaimer: Investment in the securities market is subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The Edge: Monthly Investor Insights is now out. Click the link to check the most updated funds’ performance, commentaries, and industry news: https://lnkd.in/gfz5WfxE #AlternativeInvestments #Alternatives #NextEdgeCapital

When you look at ASX investor sentiment data and understand what investors really care about, there are some pretty clear themes that jump out. Accessibility, consistency, democratising information... all of which align with Diolog's mission.

Absolute Connect Webinar | ‘Funky Correlations & Missing Links’ Each Friday at 3pm, one of the analysts from our highly experienced research team presents a 30 minute ‘Absolute Connect’ webinar, on a topic that is key to global markets. This week, ASR’s Co-founder and Head of Research, David Bowers, discussed his latest ‘Funky Correlations’ report. In this 30-minute webinar, David focused on the powerful relationships that come out of output-gap analysis, when thinking about strategic asset allocation. He also introduced ASR’s new ‘Equity-Pair Generator’, which allows us to create ‘Funky’ correlations around Equity markets and Sectors. If you are interested in attending future Absolute Connect Webinars, which are exclusive to ASR clients, then please contact our Sales team: https://lnkd.in/eTPw36RH #webinar #assetallocation #correlations #equity #strategy #investment #macro #research

📰 Our #CapitalMarketsInsight #newsletter is free of charge and provides the latest insights into developments on #CapitalMarkets. 💡 The new DAX capping rule 🎉 Bell Ringing events and jubilees ☀ New strategy of Deutsche Börse “Horizon 2026” 🔸 Review of our Deutsches Eigenkapitalforum – Europe's leading capital market conference This newsletter is published four times a year (German language only) – register now and never miss an update again:

Stifel’s Mid-2024 Halftime Report, packed with DealForma data, on the Biotech Market highlights the mixed investor sentiment, strong mid-sized M&A activity, improving inflation, and a predicted robust but bumpy market recovery for the rest of the year. Explore the Stifel’s research. https://hubs.ly/Q02GQP-90

Alert to ULI NY members! Join today's 2pm Conversation with Scott Rechler of RXR in a webinar. The topic: Opportunistic Funds Take Aim at Looming Distress: ULI Conversation with Scott Rechler of RXR | ULI Americas https://lnkd.in/e5pTXHK3